We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Bleeding Problems-Reply

Richard Gleckman, MD; Nelson M. Gantz, MD
Arch Intern Med. 1983;143(1):184. doi:10.1001/archinte.1983.00350010195048.
Text Size: A A A
Published online


In Reply.  —The first-generation cephalosporins have enjoyed wide popularity as prophylactic agents to prevent postoperative infections in specific surgical procedures classified as "clean" and "clean-contaminated."1 The universal application of these agents for these defined indications can be attributed to the following factors: these antibiotics are nontoxic, relatively inexpensive, and possess activity for those major pathogens (ie, Staphylococcus aureus or coliforms) likely to be encountered in the operative area. Confirmation of their efficacy in selective procedures has been repeatedly documented in prospective, randomized, controlled studies.2,3We believe the third-generation cephalosporins are not indicated for perioperative prophylaxis. These compounds exert less activity for S aureus. Although the third-generation cephalosporins exert greater activity against the Enterobacteriaceae than the first-generation or second-generation cephalosporins, the preferred prophylactic agent need not be active against every bacterial species present. Third-generation cephalosporins are considerably more expensive than first-generation cephalosporins, and no study has proved their clinical


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.